146 related articles for article (PubMed ID: 37071968)
21. Body Composition and Response and Outcome of Neoadjuvant Treatment for Pancreatic Cancer.
Jin K; Tang Y; Wang A; Hu Z; Liu C; Zhou H; Yu X
Nutr Cancer; 2022; 74(1):100-109. PubMed ID: 33629916
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant chemotherapy
Li Y; Ma FH; Xue LY; Tian YT
World J Gastroenterol; 2020 Feb; 26(8):818-827. PubMed ID: 32148379
[TBL] [Abstract][Full Text] [Related]
23. Skeletal muscle wasting during neoadjuvant therapy as a prognosticator in patients with esophageal and esophagogastric junction cancer: A systematic review and meta-analysis.
Wang P; Wang S; Li X; Lin G; Ma Y; Xiao R; Li H; Qiu M; Yang F
Int J Surg; 2022 Jan; 97():106206. PubMed ID: 34990833
[TBL] [Abstract][Full Text] [Related]
24. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
[No Abstract] [Full Text] [Related]
25. Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis.
Mokdad AA; Minter RM; Zhu H; Augustine MM; Porembka MR; Wang SC; Yopp AC; Mansour JC; Choti MA; Polanco PM
J Clin Oncol; 2017 Feb; 35(5):515-522. PubMed ID: 27621388
[TBL] [Abstract][Full Text] [Related]
26. Impact of body composition on clinical outcomes in people with gastric cancer undergoing radical gastrectomy after neoadjuvant treatment.
Zhang Y; Li Z; Jiang L; Xue Z; Ma Z; Kang W; Ye X; Liu Y; Jin Z; Yu J
Nutrition; 2021 May; 85():111135. PubMed ID: 33556785
[TBL] [Abstract][Full Text] [Related]
27. Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis.
Paiella S; Azzolina D; Trestini I; Malleo G; Nappo G; Ricci C; Ingaldi C; Vacca PG; De Pastena M; Secchettin E; Zamboni G; Maggino L; Corciulo MA; Sandini M; Cereda M; Capretti G; Casadei R; Bassi C; Mansueto G; Gregori D; Milella M; Zerbi A; Gianotti L; Salvia R
Front Nutr; 2023; 10():1065294. PubMed ID: 36860690
[TBL] [Abstract][Full Text] [Related]
28. Impact of neoadjuvant therapy followed by laparoscopic radical gastrectomy with D2 lymph node dissection in Western population: A multi-institutional propensity score-matched study.
Bracale U; Corcione F; Pignata G; Andreuccetti J; Dolce P; Boni L; Cassinotti E; Olmi S; Uccelli M; Gualtierotti M; Ferrari G; De Martini P; Bjelović M; Gunjić D; Cuccurullo D; Sciuto A; Pirozzi F; Peltrini R
J Surg Oncol; 2021 Dec; 124(8):1338-1346. PubMed ID: 34432291
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant therapy for pancreatic cancer: an intention-to-treat analysis.
Okada K; Murakami Y; Uemura K; Kondo N; Nakagawa N; Seo S; Otsuka H; Takahashi S
Langenbecks Arch Surg; 2020 Aug; 405(5):623-633. PubMed ID: 32592044
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of follow-up treatment regimens for colorectal cancer liver metastases without objective response to neoadjuvant chemotherapy: direct surgery or surgery after second-line chemotherapy].
Lyu XY; Bi XY; Zhao H; Chen QC; Luo ZW; Zhang BL; Zhang XS; Cai JQ
Zhonghua Wai Ke Za Zhi; 2022 May; 60(5):454-460. PubMed ID: 35359087
[No Abstract] [Full Text] [Related]
31. Correlation of body composition in early pregnancy on gestational diabetes mellitus under different body weights before pregnancy.
Xintong L; Dongmei X; Li Z; Ruimin C; Yide H; Lingling C; Tingting C; Yingying G; Jiaxin L
Front Endocrinol (Lausanne); 2022; 13():916883. PubMed ID: 36387861
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China.
Zhang G; Zhang C; Sun N; Xue L; Yang Z; Fang L; Zhang Z; Luo Y; Gao S; Xue Q; Mu J; Gao Y; Tan F; He J
J Cancer Res Clin Oncol; 2022 Apr; 148(4):943-954. PubMed ID: 34013382
[TBL] [Abstract][Full Text] [Related]
33. Postoperative BMI Loss at One Year Correlated with Poor Outcomes in Chinese Gastric Cancer Patients.
Wang N; Jiang J; Xi W; Wu J; Zhou C; Shi M; Wang C; Zhu Z; Liu J; Zhang J
Int J Med Sci; 2020; 17(15):2276-2284. PubMed ID: 32922192
[No Abstract] [Full Text] [Related]
34. Survival benefit of adjuvant chemotherapy following neoadjuvant therapy and oesophagectomy in oesophageal adenocarcinoma.
Kamarajah SK; Markar SR; Phillips AW; Kunene V; Fackrell D; Salti GI; Dahdaleh FS; Griffiths EA
Eur J Surg Oncol; 2022 Sep; 48(9):1980-1987. PubMed ID: 35718676
[TBL] [Abstract][Full Text] [Related]
35. 18F-fluorodeoxyglucose PET/computed tomography and risk stratification after neoadjuvant treatment in esophageal cancer patients.
Cervino AR; Pomerri F; Alfieri R; Sileni VC; Castoro C; Galuppo S; Evangelista L
Nucl Med Commun; 2014 Feb; 35(2):160-8. PubMed ID: 24220054
[TBL] [Abstract][Full Text] [Related]
36. The Association Between Neoadjuvant Therapy and Pathological Outcomes in Pancreatic Cancer Patients After Resection: Prognostic Significance of Microscopic Venous Invasion.
Kubo H; Ohgi K; Sugiura T; Ashida R; Yamada M; Otsuka S; Yamazaki K; Todaka A; Sasaki K; Uesaka K
Ann Surg Oncol; 2022 Aug; 29(8):4992-5002. PubMed ID: 35368218
[TBL] [Abstract][Full Text] [Related]
37. The Impact of Hospital Neoadjuvant Therapy Utilization on Survival Outcomes for Pancreatic Cancer.
Fisher AV; Abbott DE; Venkatesh M; Leverson GE; Campbell-Flohr SA; Ronnekleiv-Kelly SM; Greenberg CC; Winslow ER; Weber SM
Ann Surg Oncol; 2018 Sep; 25(9):2661-2668. PubMed ID: 30003452
[TBL] [Abstract][Full Text] [Related]
38. A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer.
Ozer M; Goksu SY; Sanford NN; Porembka M; Khurshid H; Ahn C; Maxwell MC; Beg MS; Kazmi SM
JAMA Netw Open; 2022 Feb; 5(2):e2146912. PubMed ID: 35171262
[TBL] [Abstract][Full Text] [Related]
39. The effect of neoadjuvant imatinib therapy on outcome and survival in rectal gastrointestinal stromal tumors: A multiinstitutional study.
Yang W; Liu Q; Lin G; Zhang B; Cao H; Zhao Y; Xia L; Feng F; Xiong Z; Hu J; Ye Y; Tao K; Zhang P
J Surg Oncol; 2021 Dec; 124(7):1128-1135. PubMed ID: 34324197
[TBL] [Abstract][Full Text] [Related]
40. Effect of skeletal muscle loss during neoadjuvant imatinib therapy on clinical outcomes in patients with locally advanced GIST.
Ding P; Guo H; He X; Sun C; Lowe S; Bentley R; Zhou Q; Yang P; Tian Y; Liu Y; Yang L; Zhao Q
BMC Gastroenterol; 2022 Aug; 22(1):399. PubMed ID: 36028812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
